These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 12048370)

  • 1. Impact of adherence and highly active antiretroviral therapy on survival in HIV-infected patients.
    García de Olalla P; Knobel H; Carmona A; Guelar A; López-Colomés JL; Caylà JA
    J Acquir Immune Defic Syndr; 2002 May; 30(1):105-10. PubMed ID: 12048370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
    Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
    J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to On-Time ART Drug Pick-Up and Its Association with CD4 Changes and Clinical Outcomes Amongst HIV Infected Adults on First-Line Antiretroviral Therapy in Nigerian Hospitals.
    Anoje C; Agu KA; Oladele EA; Badru T; Adedokun O; Oqua D; Khamofu H; Adebayo O; Torpey K; Chabikuli ON
    AIDS Behav; 2017 Feb; 21(2):386-392. PubMed ID: 27388161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.
    Stringer JS; Zulu I; Levy J; Stringer EM; Mwango A; Chi BH; Mtonga V; Reid S; Cantrell RA; Bulterys M; Saag MS; Marlink RG; Mwinga A; Ellerbrock TV; Sinkala M
    JAMA; 2006 Aug; 296(7):782-93. PubMed ID: 16905784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy.
    Gordillo V; del Amo J; Soriano V; González-Lahoz J
    AIDS; 1999 Sep; 13(13):1763-9. PubMed ID: 10509579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.
    de Martino M; Tovo PA; Balducci M; Galli L; Gabiano C; Rezza G; Pezzotti P
    JAMA; 2000 Jul; 284(2):190-7. PubMed ID: 10889592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.
    Eldred LJ; Wu AW; Chaisson RE; Moore RD
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):117-25. PubMed ID: 9637576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes.
    Nachega JB; Hislop M; Dowdy DW; Chaisson RE; Regensberg L; Maartens G
    Ann Intern Med; 2007 Apr; 146(8):564-73. PubMed ID: 17438315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiretroviral therapy adherence, medication use, and health care costs during 3 years of a community pharmacy medication therapy management program for Medi-Cal beneficiaries with HIV/AIDS.
    Hirsch JD; Gonzales M; Rosenquist A; Miller TA; Gilmer TP; Best BM
    J Manag Care Pharm; 2011 Apr; 17(3):213-23. PubMed ID: 21434698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of HIV progression and assessment of the optimal time to initiate highly active antiretroviral therapy: PISCIS Cohort (Spain).
    Jaén A; Esteve A; Miró JM; Tural C; Montoliu A; Ferrer E; Riera M; Segura F; Force L; Sued O; Vilaró J; Garcia I; Masabeu A; Altès J; Coltet B; Podzamczer D; Murillas J; Navarro G; Gatell JM; Casabona J;
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):212-20. PubMed ID: 18297762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival analysis on HIV/AIDS patients who began receiving antiretroviral therapy from 2005 to 2015 in Tianjin].
    Guo Y; Zhou N; Zhao FN; Liu ZQ; Li L; Yu MH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Aug; 40(8):936-940. PubMed ID: 31484257
    [No Abstract]   [Full Text] [Related]  

  • 12. [Survival and immune response of rural HIV/AIDS patients after free antiretroviral therapy].
    Ding YY; Jia WQ; Wang JS; Dong SL; Yang QH; Zhou RY; Qu SX; Lu LX; Wei J; Qiao XC; Gao MY; Guo XL; Zhang TJ; Wu ZY; He N
    Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Dec; 29(12):1176-80. PubMed ID: 19173958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-adherence among patients initiating antiretroviral therapy: a challenge for health professionals in Brazil.
    Bonolo Pde F; César CC; Acúrcio FA; Ceccato Md; de Pádua CA; Alvares J; Campos LN; Carmo RA; Guimarães MD
    AIDS; 2005 Oct; 19 Suppl 4():S5-13. PubMed ID: 16249654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of baseline viral load and adherence on survival of HIV-infected adults with baseline CD4 cell counts > or = 200 cells/microl.
    Wood E; Hogg RS; Yip B; Moore D; Harrigan PR; Montaner JS
    AIDS; 2006 May; 20(8):1117-23. PubMed ID: 16691062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy.
    Hogg RS; Yip B; Chan KJ; Wood E; Craib KJ; O'Shaughnessy MV; Montaner JS
    JAMA; 2001 Nov; 286(20):2568-77. PubMed ID: 11722271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of adherence on CD4 cell count responses among HIV-infected patients.
    Wood E; Hogg RS; Yip B; Harrigan PR; O'Shaughnessy MV; Montaner JS
    J Acquir Immune Defic Syndr; 2004 Mar; 35(3):261-8. PubMed ID: 15076240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C and progression of HIV disease.
    Sulkowski MS; Moore RD; Mehta SH; Chaisson RE; Thomas DL
    JAMA; 2002 Jul; 288(2):199-206. PubMed ID: 12095384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults.
    Nachega JB; Hislop M; Dowdy DW; Lo M; Omer SB; Regensberg L; Chaisson RE; Maartens G
    J Acquir Immune Defic Syndr; 2006 Sep; 43(1):78-84. PubMed ID: 16878045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.